A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
Clinical trial NCT00476112 · COMPLETED
Trial details
- NCT number
- NCT00476112
- Sponsor
- Advanz Pharma
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2004-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.